Colo. Rev. Stat. § 10-16-1408
Colorado prescription drug affordability review board - judicial review
Colorado · Colorado Revised Statutes Title 10 — Insurance · Status: effective
Cite this
- Citation
- Colo. Rev. Stat. § 10-16-1408, Colorado prescription drug affordability review board - judicial review, Colorado, version 1 as recorded 2026-10-03, yourstate.us, https://yourstate.us/provision/2288971
- Permanent ID
ys:prov:2288971@1- SHA-256
0cb20120069832c04d8e64be55eac763466df7c68bafb990f983ec543dd089db
The hash is SHA-256 of this version's text, with every run of whitespace collapsed to a single space and the ends trimmed. The ID always leads back here, and checking it says whether the text you cited is still the current version.
Full text
(1) The following board functions are not final agency actions subject to judicial review under the "State Administrative Procedure Act", article 4 of title 24:
(a) Identification of eligible prescription drugs pursuant to section 10-16-1406 (1);
(b) Selection of a prescription drug pursuant to section 10-16-1406 (2); and
(c) Determination that a prescription drug is unaffordable pursuant to section 10-16-1406 (3).
(2) A rule of the board establishing an upper payment limit is a final agency action subject to judicial review under the "State Administrative Procedure Act", article 4 of title 24. A party seeking judicial review of a rule establishing an upper payment limit may seek review of whether the prescription drug satisfies the necessary criteria in section 10-16-1406 to be eligible for an upper payment limit.
(3) Repealed.
(4) Notwithstanding any provision of law to the contrary:
(a) An individual may request an expedited review, as described in section 10-16-113.5, of access to a prescription drug that is unavailable to the individual because a manufacturer refuses to make the drug available as a result of an upper payment limit established for the prescription drug by the board; and
(b) A carrier may disregard the upper payment limit if the independent external review entity that performs the expedited review determines pursuant to such review that the prescription drug should be covered for and available to that individual.